Radhakrishnan noted that the awareness of dry eye in glaucoma patients had been increasing, and the availability of more ...

Emerging technologies, such as remote tonometry and genetic risk scoring, are revolutionizing glaucoma care by enabling ...

Outlook Therapeutics has re-submitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

We asked ophthalmologists what stands out to them in the history of treating glaucoma and where future treatments might be heading.

The procedure offers a renewed approach to suprachoroidal drainage, with potential for both combined and standalone glaucoma surgery.

The Elios procedure increased aqueous humor outflow in all investigated eyes, but further studies are needed to correlate these improvements with its clinical efficacy.

At the Envision Summit 2025 in San Juan, Puerto Rico, Sara Wester, MD, discussed the Women Leaders in Eye Health session at the conference and the donation from Orbis that supported the session.

The company announced it has successfully started imaging patients with its first prototype of its device using both ...

The device offers a shortened procedure time and efficient, effective SMILE for patients with myopia, with or without ...

Bonnie Henderson, MD, founder and program director of the EnVision Summit, talked with Ophthalmology Times about the ...

Perceive Pharma raised $15M in Series A funding to develop neuroprotective therapeutics for glaucoma and other conditions.

Patient discussions are crucial for tailoring IOL choices, ensuring alignment with lifestyle, needs, and surgical outcome ...